Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

3.80
Delayed Data
As of 3:59pm ET
 -0.05 / -1.30%
Today’s Change
1.10
Today|||52-Week Range
5.30
+181.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues7.0M6.8M7.2M7.0M
 
 
 
 
 
Cost of Goods Sold3.7M3.9M3.7M3.6M
 
 
 
 
 
Depreciation And Amortization585.0K572.0K613.0K617.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.7M2.3M3.0M2.8M
 
 
 
 
 
General Expenses6.7M6.3M6.4M5.5M
 
 
 
 
 
Research And Development1.7M1.6M1.1M1.1M
 
 
 
 
 
Total Operating Expenses11.0M10.8M10.7M9.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-4.0M-3.5M-2.8M
 
 
 
 
 
Extraordinary Credit67.0K730.0K829.0K0.00
 
 
 
 
Extraordinary Charge0.000.000.00-7.5M
 
 
Pre-Tax Equity Earnings-15.0K-18.0K-28.0K-12.0K
 
 
 
 
 
Interest Expense On Debt107.0K111.0K110.0K194.0K
 
 
 
 
 
Other Expenses0.00-325.0K0.00-46.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-3.7M-2.8M-10.6M
 
 
 
 
 
Income Taxes0.000.000.00-970.0K
 
 
Net Income-4.0M-3.7M-2.8M-9.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.5M16.5M18.8M18.9M
 
 
 
 
 
Shares To Calculate EPS Diluted14.5M16.5M18.8M18.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.28-$0.23-$0.15-$0.51
 
 
 
 
 
EPS Diluted-$0.28-$0.23-$0.15-$0.51